Heart Failure: Cardio-oncology
Tracks
Track 5
| Saturday, August 8, 2026 |
| 10:30 AM - 12:00 PM |
Speaker
A/Prof Michael Fradley
University of Pennsylvania
From surveillance to prevention: Pathways that reduce heart failure events and avoid stopping cancer therapy
10:30 AM - 10:50 AMBiography
Dr. Fradley is an attending cardiologist/electrophysiologist and Medical Director, Penn Cardio-Oncology Program and Associate Professor of Clinical Medicine at the University of Pennsylvania. He is board certified in Cardiovascular Disease as well as Internal Medicine.
He then went on to complete fellowships in both Cardiology and Clinical Cardiac Electrophysiology at Massachusetts General Hospital. Dr. Fradley’s current research interests involve the treatment and prevention of cardiovascular disease in cancer patients and survivors. He has published multiple articles and also served on many committees including the Massachusetts Medical Society Committee on Medical Education and the University of South Florida LCME Faculty Affairs committee. He is also heavily involved in medical education, teaching cardiovascular pathophysiology to second year medical students, and serving as the medical director for the Harvey Simulation course.
He completed his undergraduate training, with a major in Molecular Biophysics and Biochemistry, at Yale University, where he graduated cum laude with distinction in major. He received his MD degree at the Johns Hopkins School of Medicine, and then remained at Johns Hopkins, completing his residency in Internal Medicine through the Osler Medical Residency Program.Dr. Fradley is an attending cardiologist/electrophysiologist and an Assistant Professor of Medicine at the University of South Florida, Morsani College of Medicine. He serves as the director of the joint USF-Moffitt Cancer Center Cardio-Oncology Program. He is board certified in Cardiovascular Disease, clinical cardiac electrophysiology, as well as Internal Medicine.He completed his undergraduate training, with a major in Molecular Biophysics and Biochemistry, at Yale University, where he graduated cum laude with distinction in major. He received his MD degree at the Johns Hopkins School of Medicine, and then remained at Johns Hopkins, completing his residency in Internal Medicine through the Osler Medical Residency Program.He then went on to complete fellowships in both Cardiology and Clinical Cardiac Electrophysiology at Massachusetts General Hospital. Dr. Fradley’s current research interests involve the treatment and prevention of cardiovascular disease in cancer patients and survivors. He has published multiple articles and also served on many committees including the Massachusetts Medical Society Committee on Medical Education and the University of South Florida LCME Faculty Affairs committee. He is also heavily involved in medical education, teaching cardiovascular pathophysiology to second year medical students, and serving as the medical director for the Harvey Simulation course.
Prof Doan Ngo
Professor
Hunter Medical Research Institute / University of Newcastle
Mechanisms to medicines: How we discover cardioprotective strategies without compromising anti-cancer efficacy
10:50 AM - 11:05 AMBiography
Dr Satish Ramkumar
Consultant Cardiologist
Victorian Heart Hospital
Biomarkers, imaging triggers and when to do when EF/GLS fails
11:05 AM - 11:20 AMBiography
Prof Javid Moslehi
UCSF Cardiovascular Research Institute
Myocarditis ICI and beyond
11:20 AM - 11:35 AMBiography
Dr. Javid Moslehi is a cardiologist who specializes in the cardiovascular health of cancer patients, cancer survivors and patients with immunological or metabolic problems that affect cardiovascular health. He serves as chief of UCSF's cardio-oncology and immunology section.
Moslehi's research focuses on how diseases of the cardiovascular system impact cancer patients and survivors. He is also interested in inflammatory heart conditions, such as myocarditis.
Moslehi earned his medical degree from the University of Connecticut School of Medicine. He completed a residency in internal medicine at the Johns Hopkins Hospital. At Brigham and Women's Hospital, he completed a fellowship in cardiology and a postdoctoral research fellowship in oncology. His career includes directing cardio-oncology programs at the Dana-Farber Cancer Institute and Vanderbilt University Medical Center. He is the UCSF William Grossman Distinguished Professor in Cardiology.
Dr Trent Williams
Clinical Nurse Consultant
Hunter New England Local Health District
Rapid access/nurse leg cardio-onc clinics: Scaling prevention + equity for regional and rural patients
11:35 AM - 11:50 AMBiography
